These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 12661898)

  • 1. Diagnostic value of urine deoxypyridinoline for detecting bone metastases in breast cancer patients.
    Hou MF; Lin SB; Yuan SS; Tsai LY; Tsai SM; Hsieh JS; Huang TJ
    Ann Clin Lab Sci; 2003; 33(1):55-61. PubMed ID: 12661898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The course of the urinary DPD-crosslink secretion in metastatic breast cancer--a possibility for response assessment.
    Lüftner D; Günther S; Flath B; Müller C; Echteroff K; Mergenthaler HG; Wernecke KD; Possinger K
    Anticancer Res; 1999; 19(4A):2537-44. PubMed ID: 10470191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical markers for assessment of bone metastases in patients with breast cancer.
    Hou MF; Tsai LY; Tsai SM; Huang CJ; Huang YS; Hsieh JS; Chan HM; Wang JY; Chuang CH; Chen FM; Huang TJ
    Kaohsiung J Med Sci; 1999 Aug; 15(8):452-60. PubMed ID: 10518361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine calcium and deoxypyridinoline in assessment of response to local radiation therapy for metastatic bone disease.
    Topkan E; Karaoglu A
    J Exp Clin Cancer Res; 2007 Dec; 26(4):553-9. PubMed ID: 18365552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion of deoxypyridinoline in patients with breast cancer.
    Nguyen-Pamart M; Bonneterre J; Hecquet B
    Anticancer Res; 1995; 15(4):1601-3. PubMed ID: 7654055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The amino-terminal propeptide (PINP) of type I collagen is a clinically valid indicator of bone turnover and extent of metastatic spread in osseous metastatic breast cancer.
    Pollmann D; Siepmann S; Geppert R; Wernecke KD; Possinger K; Lüftner D
    Anticancer Res; 2007; 27(4A):1853-62. PubMed ID: 17649784
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The clinical usefulness of urinary pyridinoline and deoxypyridinoline as potential markers of bone metastasis in patients with prostate cancer].
    Takeuchi S; Saitoh H
    Nihon Rinsho; 1998 Aug; 56(8):2077-81. PubMed ID: 9750511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Relationship of osteolytic biochemical indicators of bone metabolism with the therapeutic effect in breast cancer patients with bone metastases].
    Li SF; Wang XR; Wang C; Chen Y; Ren L; Cui L; Tong ZS
    Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):911-5. PubMed ID: 20193330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of urinary collagen cross-links indicate response to therapy in patients with breast cancer and bone metastases.
    Walls J; Assiri A; Howell A; Rogers E; Ratcliffe WA; Eastell R; Bundred NJ
    Br J Cancer; 1999 Jun; 80(8):1265-70. PubMed ID: 10376982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of bone resorption--measurement in serum, plasma or urine?
    Huber F; Traber L; Roth HJ; Heckel V; Schmidt-Gayk H
    Clin Lab; 2003; 49(5-6):203-7. PubMed ID: 15285175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of bone-related biomarkers and CA27.29 to assess response to treatment of osseous metastatic breast cancer.
    Lüfter D; Richter A; Günther S; Flath B; Akrivakis C; Geppert R; Wernecke KD; Possinger K
    Anticancer Res; 2000; 20(6D):5099-105. PubMed ID: 11326676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of methods for measuring serum and urinary markers of bone metabolism in cats.
    DeLaurier A; Jackson B; Pfeiffer D; Ingham K; Horton MA; Price JS
    Res Vet Sci; 2004 Aug; 77(1):29-39. PubMed ID: 15120950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of bone remodelling markers in patients with bone metastases treated with zoledronic acid.
    Pectasides D; Nikolaou M; Farmakis D; Kanakis I; Gaglia A; Kountourakis P; Karamanos NK; Economopoulos T; Raptis SA
    Anticancer Res; 2005; 25(2B):1457-63. PubMed ID: 15865105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The biochemical markers of bone remodeling in cancer patients with skeletal involvement].
    Liubimova NV; Bronnikov IIu; Robins SP; Trapeznikova MF; Kushlinskiĭ NE
    Vopr Onkol; 2000; 46(3):290-7. PubMed ID: 10976274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical usefulness of measurements of urinary deoxypyridinoline (DPD) in patients with postmenopausal osteoporosis receiving intermittent cyclical etidronate: advantage of free form of DPD over total DPD in predicting treatment efficacy.
    Kitatani K; Nakatsuka K; Naka H; Miki T; Morii H; Nishizawa Y
    J Bone Miner Metab; 2003; 21(4):217-24. PubMed ID: 12811626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy.
    Clemons MJ; Dranitsaris G; Ooi WS; Yogendran G; Sukovic T; Wong BY; Verma S; Pritchard KI; Trudeau M; Cole DE
    J Clin Oncol; 2006 Oct; 24(30):4895-900. PubMed ID: 17001071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of pyridinium crosslinks and CA 15-3 as markers in metastatic bone breast carcinoma.
    Massidda B; Ionta MT; Foddi MR; Mascia L; Bruder F; Aloi MB; Meleddu C; Giannoni MN
    Anticancer Res; 1996; 16(4B):2221-3. PubMed ID: 8694547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
    Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
    J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of biochemical indices as metastatic markers in patients with prostatic cancer invading skeleton].
    Liubimova NV; Trapeznikova MF; Robins SP; Ognerubov SA; Kushlinskiĭ NE
    Urologiia; 2000; (4):15-9. PubMed ID: 11186686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reference value for urinary deoxypyridinoline as a specific marker for measuring bone resorption in Thais.
    Pidetcha P; Intramanee S; Patrakarn K; Leelahakul P; Fongsupa S
    J Med Assoc Thai; 1999 Nov; 82(11):1136-41. PubMed ID: 10659549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.